Epstein-Barr virus and multiple sclerosis

Journal of the Neurological Sciences

Volumn 286, Issue 1-2, 2009, Pages 62-64

  Pohl, Daniela ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Autoimmunity; Chronic infection; CNS infection; Demyelination; Epstein Barr virus; Infectious mononucleosis; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; VIRUS DNA;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC DISEASE; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFECTIOUS MONONUCLEOSIS; MEMORY CELL; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; T LYMPHOCYTE SUBPOPULATION;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MULTIPLE SCLEROSIS;

EID: 70349773294     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.03.028     Document Type: Article

References (45)

1. Murray T.J. Multiple sclerosis: the history of a disease (2005), Demos Medical Publishing, New York 179
2. Lünemann J.D., and Muenz C. Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 7 (2007) 253-258
3. Sumaya C.V., Myers L., and Ellison G.W. Epstein-Barr virus antibodies in multiple sclerosis. Trans Am Neurol Ass 101 (1976) 300-302
4. Sumaya C.V., Myers L.W., and Ellison G.W. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 37 (1980) 94-96
5. Bray P.F., Bloomer L.C., and Salmon V.C. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 40 (1983) 406-408
6. Sumaya C.V., Myers L.W., Ellison G.W., and Ench Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17 (1985) 371-377
7. Larsen P.D., Bloomer L.C., and Bray P.F. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 35 (1985) 435-438
8. Shirodaria P.V., Haire M., Fleming E., Merrett J.D., Hawkins Sa., and Roberts S.D. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 44 (1987) 1237-1241
9. Ascherio A., Munger K.L., Lennette E.T., Spiegelman D., Hernán M.A., Olek M.J., et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 26 (2001) 3083-3088
10. Villoslada P., Juste C., Tintore M., Llorenç V., Codina G., Pozo-Rosich P., et al. The immune response against herpesvirus is more prominent in the early stages of MS. Neurology 60 (2003) 1944-1948
11. Sundström P., Juto P., Wadell G., Hallmans G., Svenningsson A., Nyström L., et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62 (2004) 2277-2282
12. Haahr S., Plesner Am., Vestergaard B.F., and Höllsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand 109 (2004) 270-275
13. Levin L.I., Munger K.L., Rubertone M.V., Peck C.A., Lennette E.T., Spiegelman D., et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293 (2005) 2496-2500
14. Myhr K.M., Riise T., Barrett-Connor E., Myrmel H., Vedeler C., Gronning M., et al. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 64 (1998) 539-542
15. Buljevac D., van Doornum G.J.J., Flach H.Z., Groen J., Osterhaus A.D., Hop W., et al. Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76 (2005) 1377-1381
16. DeLorenze G.N., Munger K.L., Lennette E.T., Orentreich N., Vogelman J.H., and Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of an association from a prospective study with long-term follow-up. Arch Neurol 63 (2006) 839-844
17. De Jager P.L., Simon K.C., Munger K.L., Rioux J.D., Hafler D.A., and Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70 (2008) 1113-1118
18. Banwell B., Krupp L., Kennedy J., Tellier R., Tenembaum S., Ness J., et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6 (2007) 773-781
19. Pohl D., Krone B., Rostasy K., Kahler E., Brunner E., Lehnert M., et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67 (2006) 2063-2065
20. Alotaibi S., Kennedy J., Tellier R., Stephens D., and Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291 (2004) 1875-1879
21. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Büssow K., et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115 (2005) 1352-1360
22. James J.A., Neas B.R., Moser K.L., Hall T., Bruner G.R., Sestak A.L., et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 44 (2001) 1122-1126
23. McClain M.T., Poole B.D., Bruner B.F., Kaufman K.M., Harley J.B., and James J.A. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum 54 (2006) 360-368
24. Krone B., Pohl D., Rostasy K., Kahler E., Brunner E., Oeffner F., et al. Common infectious agents in multiple sclerosis: a case control study in children. Mult Scler 14 (2008) 136-139
25. Thacker E.L., Mirzaei F., and Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59 (2006) 499-503
26. Nielsen T.R., Rostgaard K., Nielsen N.M., Frisch M., and Hjalgrim H. Multiple sclerosis after infectious mononucleosis. Arch Neurol 64 (2007) 72-75
27. Derfuss T., Gürkov R., Then Bergh F., Goebels N., Hartmann M., Barz C., et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124 (2001) 1325-1335
28. Reiber H., and Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184 (2001) 101-122
29. Burgoon M.P., Hammack B.N., Owens G.P., Maybach A.L., Eikelenboom M.J., and Gilden D.H. Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol 54 (2003) 459-463
30. Rand K.H., Houck H., Denslow N.D., and Heilman K.M. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis. J Neurol Sci 173 (2000) 32-39
31. Reiber H., Ungefehr S., and Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4 (1998) 111-117
32. Derfuss T., Hohlfeld R., and Meinl E. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol 252 (2005) 968-971
33. Rostasy K., Reiber H., Pohl D., Lange P., Ohlenbusch A., Eiffert H., et al. Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies. Neurology 61 (2003) 125-128
34. Franciotta D., Yardini E., Bergamaschi R., Grimaldi L.M., Andreoni L., and Cosi V. Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurological diseases. Acta Neurol Scand 112 (2005) 238-241
35. Lünemann J.D., Edwards N., Muraro P.A., Hayashi S., Cohen J.I., Munz C., et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-I-specific T-cells in multiple sclerosis. Brain 129 (2006) 1493-1506
36. Jilek S., Schluep M., Meylan P., Vingerhoets F., Guignard L., Monney A., et al. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 131 (2008) 1712-1721
37. Holmoy T., Kvale E.O., and Vartdal F. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirology 10 (2004) 278-283
38. Lünemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 205 (2008) 1763-1773
39. Wucherpfennig K.W., and Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80 (1995) 695-705
40. Lang H.L.E., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3 (2002) 940-943
41. Martin C., Enbom M., Söderström M., Fredrikson S., Dahl H., Lycke J., et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 95 (1997) 280-283
42. Mancuso R., Delbue S., Borghi E., Pagani E., Calvo M.G., Caputo D., et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 79 (2007) 192-199
43. Alvarez-Lafuente R., García-Montojo M., De Las Heras V., Domínguez-Mozo M.I., Bartolome M., Benito-Martin M.S., et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler 14 (2008) 595-601
44. Sanders V.J., Felisan S., Waddell A., and Tourtellotte W.W. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2 (1996) 249-258
45. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., et al. Dysregulated Epstein-Barr infection in the multiple sclerosis brain. J Exp Med 204 (2007) 2899-2912